Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Ameriprise Gains Most Since 2012 as Profit Climbs

Don't Miss Out —
Follow us on:

April 29 (Bloomberg) -- Ameriprise Financial Inc. posted the second-biggest gain in the Standard & Poor’s 500 Index after reporting profit that beat analysts’ estimates and announcing increased share buybacks.

The money manager and insurer jumped 5.8 percent to $109.55 at 4:15 p.m. in New York, the largest increase for the firm since 2012.

First-quarter net income advanced 19 percent from a year earlier to $400 million, the Minneapolis-based company said in a statement late yesterday. Operating profit of $2.04 a share beat the $1.88 average estimate of nine analysts surveyed by Bloomberg. Ameriprise raised its quarterly dividend 12 percent to 58 cents and announced the authorization of $2.5 billion in additional share repurchases over the next two years.

“Capital management continues at a robust pace,” John Nadel, an analyst at Sterne Agee & Leach Inc., wrote in a research note. “The bull case appears well intact.”

Ameriprise’s last buyback authorization, in 2012, was for $2 billion of shares. The biggest gainer in the S&P 500 today was Regeneron Pharmaceuticals Inc., which climbed 6.5 percent

To contact Bloomberg News staff for this story: Craig Giammona in New York at cgiammona@bloomberg.net

To contact the editors responsible for this story: Peter Eichenbaum at peichenbaum@bloomberg.net Dan Kraut, Steven Crabill

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.